Citation Impact
Citing Papers
Continuous glucose monitors prove highly accurate in critically ill children
2010
Nutritional and Metabolic Alterations during Continuous Renal Replacement Therapy
2013
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Diabetes, insulin, and development of acute lung injury
2009
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
2012 Standout
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease
2010
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
2011 Standout
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Pathogenesis and treatment of parenteral nutrition-associated liver disease
2012
Through The Eyes of a Child: Understanding Retinopathy through ROP The Friedenwald Lecture
2008
Retinopathy of prematurity
2013 Standout
Amino acids: metabolism, functions, and nutrition
2009 Standout
Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction
2008
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Short Bowel Syndrome and Intestinal Failure in Crohnʼs Disease
2016
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Crohn's disease
2016 Standout
Necrotizing Enterocolitis
2011 Standout
Acute respiratory distress syndrome
2019 Standout
Lipids in the intensive care unit: Recommendations from the ESPEN Expert Group
2017
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients
2007
Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteries
2004
Lipid emulsions in the treatment and prevention of parenteral nutrition–associated liver disease in infants and children–
2016
Pediatric short-bowel syndrome: the cost of comprehensive care
2008
Citrulline and the gut
2007
Arginine metabolism and nutrition in growth, health and disease
2008 Standout
Intercellular communication in cultured human vascular smooth muscle cells
2001
Home Parenteral Nutrition
2016
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Life cycle of connexins in health and disease
2006 Standout
The Metabolic Syndrome
2008 Standout
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
Dietary Phosphatidylinositol Prevents the Development of Nonalcoholic Fatty Liver Disease in Zucker (fa/fa) Rats
2008
Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease
2009
Works of Patrick J. Javid being referenced
Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation
2004
The route of lipid administration affects parenteral nutrition–induced hepatic steatosis in a mouse model
2005
First Report of the International Serial Transverse Enteroplasty Data Registry: Indications, Efficacy, and Complications
2007
The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants
2013
Serial Transverse Enteroplasty Enhances Intestinal Function in a Model of Short Bowel Syndrome
2006
Omega-3 Fatty Acid Supplementation Prevents Hepatic Steatosis in a Murine Model of Nonalcoholic Fatty Liver Disease
2005
The role of enteral nutrition in the reversal of parenteral nutrition–associated liver dysfunction in infants
2005
Inhibition of Nitric Oxide-Induced Vasodilation by Gap Junction Inhibitors: A Potential Role for a cGMP-Independent Nitric Oxide Pathway
1996
The First Use of Live Continuous Glucose Monitoring in Patients on Extracorporeal Life Support
2005